Literature DB >> 6903559

Alterations in serum opsonic activity and complement levels in pneumococcal disease.

G S Giebink, T H Dee, Y Kim, P G Quie.   

Abstract

Pneumococcal opsonic activity and concentrations of pneumococcal capsular polysaccharide antigen, C3, C4 factor B, C3 and factor B breakdown products were measured in the serum obtained acutely from 12 patients with serious pneumococcal disease. One patient showed markedly reduced pneumococcal opsonic activity, borderline-low C3, and the presence of C3 and factor B breakdown products and died. Although eight additional patients showed depressed levels of C3 or C4 or the presence of C3 or factor B breakdown products, none had reduced pneumococcal opsonic activity. All of the three remaining patients had normal opsonic activity and C3 and C4 levels. Covalescent serum was obtained from eight patients; six had normal C3 and C4 levels, and two had persistent C4 depression. These data show that complement is activated during pneumococcal disease and suggest that extensive complement activation may impair pneumococcal opsonic activity in certain patients and thereby compromise an important host defense mechanism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6903559      PMCID: PMC551239          DOI: 10.1128/iai.29.3.1062-1066.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA.

Authors:  R AUSTRIAN; J GOLD
Journal:  Ann Intern Med       Date:  1964-05       Impact factor: 25.391

2.  Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.

Authors:  J A Winkelstein; A Tomasz
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

3.  Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.

Authors:  G S Giebink; J Verhoef; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

4.  Alternative C3 pathway activiation in pneumococcal glomerulonephritis.

Authors:  L R Hyman; E H Jenis; G S Hill; S W Zimmerman; P M Burkholder
Journal:  Am J Med       Date:  1975-06       Impact factor: 4.965

5.  Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children.

Authors:  G S Giebink; J E Foker; Y Kim; G Schiffman
Journal:  J Infect Dis       Date:  1980-03       Impact factor: 5.226

6.  Clinical and bacteriological events in experimental lethal pneumococcal infection.

Authors:  J E Perry; L E Cluff
Journal:  Tex Rep Biol Med       Date:  1966

7.  Complement system in pneumococcal infections.

Authors:  W P Reed; M S Davidson; R C Williams
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

8.  Breakdown products of C3 and factor B in hemolytic-uremic syndrome.

Authors:  Y Kim; K Miller; A F Michael
Journal:  J Lab Clin Med       Date:  1977-04

9.  Immunologic studies in pneumococcal disease.

Authors:  T H Dee; G Schiffman; M I Sottile; M W Rytel
Journal:  J Lab Clin Med       Date:  1977-06

10.  The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.

Authors:  R B Johnston; M R Klemperer; C A Alper; F S Rosen
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  3 in total

1.  Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway.

Authors:  H A Verbrugh; D A Lee; G R Elliott; W F Keane; J R Hoidal; P K Peterson
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

2.  Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.

Authors:  S E Gardner; D C Anderson; B J Webb; A E Stitzel; M S Edwards; R E Spitzer; C J Baker
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

Review 3.  Streptococcus pneumoniae Otitis Media Pathogenesis and How It Informs Our Understanding of Vaccine Strategies.

Authors:  Caroline Bergenfelz; Anders P Hakansson
Journal:  Curr Otorhinolaryngol Rep       Date:  2017-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.